Market Trends of Germany Patient Care Monitoring Equipment Industry
This section covers the major market trends shaping the Germany Patient Care Monitoring Equipment Market according to our research experts:
Cardiology is Expected to Witness Significant Growth in the Germany Patient Monitoring Market Over the Forecast Period
The cardiology segment is expected to witness significant growth in the patient care monitoring equipment market in Germany over the forecast period owing to factors such as the rising burden of cardiovascular disease and its risk-associated factors and the growing adoption of cardiac monitoring devices.
Cardiac monitoring is the continuous or intermittent monitoring of heart activity with the goal of assessing the patient's condition in relation to their cardiac rhythm.Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment.
The rising prevalence of hypertension, stroke, diabetes, and other cardiovascular diseases is the key factor driving the demand for cardiac patient monitoring equipment, hence bolstering the segment's growth. For instance, as per the German Heart Surgery 2021 report, about 92,838 heart surgeries were performed in Germany in 2021, including 36,714 isolated heart valve procedures, 27,947 isolated coronary artery bypass grafting procedures, and 329 isolated heart transplantations. Thus, with the high number of cardiovascular surgeries, the patient requires regular and ongoing monitoring, which increases the demand for cardiac patient care equipment. This is anticipated to fuel segment growth over the forecast period.
Furthermore, the rising number of product launches for monitoring and early detection of heart conditions is also expected to bolster market growth. For instance, in September 2021, Withings launched a cardiac monitoring smartwatch, ScanWatch Horizon, in Germany, which includes a slew of heart-health monitoring features such as heart rate, ECG, breathing disturbances, blood oxygen levels, sleep, and physical activity tracking. This watch enables the patient to identify heart rhythms, as well as use the ECG feature to help detect atrial fibrillation.
Because of things like the growing number of people with heart disease and diabetes and the number of new products coming out, the studied segment is expected to grow over the next few years.
Neuromonitoring Devices Segment is Expected to Have the Significant Market Share Over the Forecast Period
The neuromonitoring devices segment is expected to witness significant growth in the patient care monitoring equipment market over the forecast period owing to the factors such as the rising prevalence of neurological disorders such as Parkinson's, Alzheimer's, dementia, and others and growing company activities in developing monitoring devices that help in monitoring the brain activity.
The rising burden of neurological diseases among the population is the key factor driving the demand for remote patient monitoring devices. For instance, as stated by the Alzheimer's Association 2022 report, more than 1.5 million people in Germany were suffering from Alzheimer's Disease and this number is expected to double by 2050. Additionally, according to an article published in the Neurological Research and Practice, in March 2022, it has been observed that physicians diagnosed 68.9% of German patients and 50% of international patients as having Advanced Parkinson's disease. Thus, the expected increase in the number of people suffering from Alzheimer's disease and the high number of population suffering from Parkinson's disease in the country is expected to increase the demand for neuromonitoring devices. This is anticipated to fuel the segment growth over the forecast period.
Moreover, the rising product launches are likely to contribute to the market growth over the forecast period. For instance, in September 2022, Brainlab acquired Dr. Langer Medical GmbH. This acquisition assists the company to expand its neuromonitoring portfolio by integrating advanced next-generation technologies. Also, in May 2021, WISE Srl received the CE marking of its WISE cortical Strip, a single-use medical device intended to be used on the surface of the brain for intraoperative neurophysiological monitoring.
Therefore, owing to the factors such as the rising burden of Alzheimer's and Parkinson's disease among the population and increasing product launches, the studied segment is expected to grow over the forecast period.
